Researchers at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences will be awarded the Alfred Hauptmann Prize at the “Epilepsie 2023” meeting in Berlin. Jürgen Knoblich, Nina Corsini and Oliver Eichmüller receive the prize in the category of basic research for their work on Tuberous Sclerosis. The Alfred Hauptmann Prize is awarded by the German and Austrian Societies for Epileptology (DGfE & ÖGfE) and the Swiss League Against Epilepsy. The three organizations recognize the two best scientific publications related to epilepsy, in the categories Basic Research and Clinical Research, published by researchers in the three German-speaking countries.
Read the full story on the IMBA website.